Quest Diagnostics is warning of delays in getting COVID-19 test results due to soaring consumer demand. The average turnaround time is now seven days, compared with two to three days in early June, ...
Quest Diagnostics has launched an at-home diagnostic test for COVID-19 that individuals can order online, but the out-of-pocket cost for the test could get in the way of widespread use. The test, ...
Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson's disease, today ...
Quest Diagnostics DGX invests in advanced diagnostics to deliver and scale innovative services that improve patient care and ...
Quest Diagnostics Tuesday announced it will be selling the first "at-home" COVID-19 antibody test kits. These tests are supposed to help identify a person who was exposed to or possibly even had COVID ...
SECAUCUS, N.J., Sept. 25, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report third quarter 2025 financial ...
I've been covering Quest Diagnostics for some time. While it can be argued that the company has beaten estimates, it's also clear that positive catalysts are few. I've been neutral going on for a year ...
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest ...
Quest Diagnostics (DGX) has been one of the coronavirus heroes, having performed 14.4 million COVID-19 diagnostics tests and 3.6 million antibody tests (as of September 14th). At the same time, Quest ...
Investors in Quest Diagnostics (NYSE:DGX) have made a notable return of 99% over the past five years
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than that, you probably want to see it rise more than the market average. But Quest ...
Wall Street expects a year-over-year increase in earnings on higher revenues when Quest Diagnostics (DGX) reports results for the quarter ended September 2025. While this widely-known consensus ...
Lower full-year 2018 revenue and earnings estimates cause investors to sour on the diagnostics services provider. Quest cut its 2018 revenue outlook to $7.57 billion from its previous guidance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback